Metabolic-Bariatric Surgery Reduces Pancreatic Cancer Risk: A Meta-Analysis of Over 3.7 Million Adults, Independent of Type 2 Diabetes Status.

Autor: Angelidi AM; Metabolism Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Martinou EG; Department of Upper Gastrointestinal and Bariatric Surgery, University Sussex Hospitals NHS Foundation Trust, Chichester, UK., Karamanis DG; Department of Economics, University of Piraeus, Piraeus, Greece.; Department of Health Informatics, Rutgers School of Health Professions, Newark, New Jersery, USA.

Publikováno v: Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2024 Oct; Vol. 40 (7), pp. e3844.